Surgical treatment of hepatocellular carcinoma with severe intratumoral arterioportal shunt.

We report a case of hepatocellular carcinoma (HCC) that caused a severe arterioportal shunt (APS). A 49-year-old man was admitted to hospital due to esophagogastric variceal hemorrhage and HCC, and underwent endoscopic variceal ligation (EVL) and endoscopic injection sclerotherapy (EIS). He was then referred to our hospital. Abdominal computed tomography revealed a low-density lesion in the posterior segment of the liver and an intratumoral APS, which caused portal hypertension. Although the patient underwent EVL, EIS, Hassab's operation, and transcatheter arterial embolization for APS, he vomited blood due to rupture of esophagogastric varices. Right hepatectomy was performed for the treatment of HCC and APS, although the indocyanine green retention value at 15 min after intravenous injection was poor (30%). The patient's postoperative course was uneventful. Eventually, APS disappeared and the esophagogastric varices improved.

[1]  S. Todo,et al.  Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from 99mTc‐GSA scintigraphy , 2008, Journal of gastroenterology and hepatology.

[2]  Y. Mizuguchi,et al.  Major arterioportal shunt caused by hepatocellular carcinoma. , 2007, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[3]  H. Shan,et al.  Capability of multidetector CT to diagnose hepatocellular carcinoma-associated arterioportal shunt. , 2005, World journal of gastroenterology.

[4]  M. Makuuchi,et al.  Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. , 2005, Journal of hepato-biliary-pancreatic surgery.

[5]  H. Shan,et al.  Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. , 2004, World journal of gastroenterology.

[6]  H. Miyake,et al.  Experimental study of the evaluation of liver function on the opposite side during portacaval anastomosis and ligation of the left portal branch. , 2004, The journal of medical investigation : JMI.

[7]  L. Rodrigo,et al.  Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis , 2003, Hepatology.

[8]  P. Kamath,et al.  IMAGES IN HEPATOLOGY , 1998 .

[9]  K. Man,et al.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy , 1997, The British journal of surgery.

[10]  Shou-Dong Lee,et al.  Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial , 1995, Hepatology.

[11]  K. Sniderman,et al.  Hepatoma, arterioportal shunting, and hyperkinetic portal hypertension: therapeutic embolization. , 1985, Radiology.

[12]  M. Kaneko,et al.  Angiography of primary liver cancer. , 1970, The American journal of roentgenology, radium therapy, and nuclear medicine.

[13]  Hassab Ma.  Gastroesophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: further studies with a report on 355 operations. , 1967 .

[14]  日本肝癌研究会.  General rules for the clinical and pathological study of primary liver cancer , 2010 .

[15]  P. Kamath,et al.  Images in hepatology. Arterio-portal fistula causing recurrent variceal bleeding. , 1998, Journal of hepatology.

[16]  W. Peh,et al.  Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. , 1997, Clinical radiology.

[17]  M. Kojiro,et al.  Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma. , 1977, Radiology.

[18]  M. Hassab.  Gastroesophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: further studies with a report on 355 operations. , 1967, Surgery.